Santos Carlos E
Chief Financial Officer
Santos Carlos E has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 23, 2026.
On the most recent filing, Santos Carlos E is listed as Chief Financial Officer at Legend Biotech Corp. Inside the rolling window, Santos Carlos E reported no open-market purchases and 1 open-market sale totaling $50K in LEGN.
Companies traded
Other insiders at LEGN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$50K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Santos Carlos E made?
Santos Carlos E has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Santos Carlos E trade?
Santos Carlos E has filed SEC Form 4 disclosures for 1 company, including LEGN.
When was Santos Carlos E's most recent SEC Form 4 filing?
Santos Carlos E's most recent SEC Form 4 filing on Tracefour is dated Sep 23, 2026.
What is Santos Carlos E's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Santos Carlos E is listed as Chief Financial Officer.
What is Santos Carlos E's total buy and sell value in the current window?
Inside the rolling retention window, Santos Carlos E bought $0 and sold $50K based on SEC Form 4 filings.
What was Santos Carlos E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,430 LEGN shares on 2026-09-21, worth $50K, per SEC Form 4 filings.